← Back to All Filings

DENTSPLY SIRONA (XRAY) Director Receives Dividend-Based Stock Award

Low SignificanceOctober 15, 2025 at 5:08:47 PM EDT

DENTSPLY SIRONA Inc.

$XRAY4CIK: 0000818479

Subscribe to track XRAY

Premium users can add ticker alerts and receive realtime notification updates.

Filing Summary

DENTSPLY SIRONA (XRAY) Director Receives Dividend-Based Stock Award

Company: DENTSPLY SIRONA Inc. (XRAY) Form: 4 | Filed: 2025-10-15 Significance: Low

Insider: Gladden Brian T Title: Director

Transaction: • Type: Award (Dividend on RSUs) • Shares: 286.094 • Price: $0.00 • Value: $0 • Owned After: 28,726.563

Key Insight: This is an automatic acquisition of shares as a dividend on existing Restricted Stock Units (RSUs), not an open-market purchase. It carries low significance as it doesn't reflect a new investment decision by the insider.

Market Context: Dividend reinvestments are common and typically do not impact market sentiment.

View Full Filing

This is PUBLIC SEC data for educational purposes. Not investment advice.

Comprehensive Analysis

SEC Filing Analysis: DENTSPLY SIRONA Inc. (XRAY)

Executive Summary

  • Trading Significance: Low
  • Key Takeaway: A Director received a small number of shares as a dividend payment on existing restricted stock units (RSUs), a routine and non-discretionary transaction with no investment signal.
  • Market Impact: Neutral. This type of transaction is expected as part of a compensation plan and does not typically influence stock price or trading volume.

Company Information

FieldValue
CompanyDENTSPLY SIRONA Inc.
Ticker SymbolXRAY
CIK0000818479
IndustryDENTAL EQUIPMENT & SUPPLIES [3843]

Insider Information

FieldValue
NameGladden Brian T
CIK0001435432
Title/PositionDirector
RelationshipDirector

Transaction Details

FieldValue
Form Type4
Transaction Date2025-10-10
Transaction CodeA (Award)
Security TypeCommon Stock (acquired as RSUs)
Shares Involved286.094
Price Per Share$0.00
Total Value$0.00
Shares Owned After28,726.563
Ownership TypeDirect

Market Impact Analysis

Stock Impact Prediction

  • Direction: Neutral
  • Reasoning: The transaction is an automatic dividend reinvestment on previously granted RSUs, not a discretionary open-market trade. It does not indicate a change in the insider's outlook on the company or a new investment decision.

Volume & Sentiment

  • Expected Volume Impact: Negligible. The transaction is not an open-market trade and the number of shares is minimal relative to daily trading volume.
  • Sentiment Indicator: Neutral. This is a routine administrative transaction related to executive compensation.

Investment Insights

Positive Market Indicators

  • This filing does not contain any positive market indicators.

Risk Factors

  • This filing does not introduce any new risk factors.

Key Takeaways

  1. Non-Discretionary Transaction: The acquisition was automatic, stemming from dividends on existing RSUs, not a deliberate choice to buy more stock.
  2. Compensation-Related: This is part of the insider's compensation structure and should be viewed as such, rather than a market sentiment signal.
  3. Zero Cost Basis: The $0 price confirms it was an award, not a purchase, reinforcing its low significance for trading analysis.

Contextual Analysis

Timing Significance

  • The transaction date is likely aligned with the company's regular dividend payment schedule, making the timing routine and not indicative of any strategic move by the insider.

Transaction Context

  • The filing's footnote clarifies the nature of the transaction: "Represents dividends on restricted stock units (RSUs) awarded to the Reporting Person in the form of additional RSUs and are subject to the same vesting terms as the underlying awards." This confirms the acquisition is a feature of the original RSU grant.

Company Context

  • This transaction should be viewed in the context of DENTSPLY SIRONA's overall executive compensation strategy and dividend policy. It does not reflect any new operational or strategic developments within the company.

Risk Assessment

Risk Level: Low

Risk Factors

  • The filing itself presents no new risks to the company or its stock.

Market Considerations

  • This filing is procedural and should not be a factor in investment decisions. It is purely informational regarding an insider's holdings.

IMPORTANT DISCLAIMER: This analysis is for informational purposes only and is not intended as investment advice. The information presented is based on publicly available SEC filings and should not be construed as a recommendation to buy, sell, or hold any securities. Past performance does not guarantee future results. All investments carry risk, including the potential loss of principal. Please consult with a qualified financial advisor before making any investment decisions.

Analysis generated on 2025-10-15 | Data source: SEC EDGAR

Topics:#SECFiling#InsiderTrading#DENTSPLYSIRONA#XRAY#XRAYStock#Form4#StockAward#Director#Investing#FinancialData

Get Real-Time Alerts

Join our community to receive instant notifications when high-significance filings are published

Important Disclaimer

This content is drawn from public SEC filings and may contain errors. It is for informational purposes only and is not investment, legal, or tax advice.

Nothing here is a recommendation to buy, sell, or hold any security. Do your own due diligence.